View study details on clinicaltrials.gov.
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
A Phase 3, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Reldesemtiin Patients With Amyotrophic Lateral Sclerosis (ALS)
Location: CPMC (San Francisco)
Please contact: ClinicalResearch@sutterhealth.org about study Courage-ALS